Aspire Biopharma Holdings Inc [ASBP] moved down -0.55: Why It’s Important

Brandon Evans

Aspire Biopharma Holdings Inc [NASDAQ: ASBP] slipped around 0.0 points on Monday, while shares priced at $0.09 at the close of the session, down -0.55%.

Aspire Biopharma Holdings Inc stock is now -99.21% down from its year-to-date (YTD) trading value. ASBP Stock saw the intraday high of $0.094 and lowest of $0.0891 per share. The company’s 52-week high price is 15.80, which means current price is +10.71% above from all time high which was touched on 02/12/25.

Compared to the average trading volume of 35.47M shares, ASBP reached a trading volume of 8011518 in the most recent trading day, which is why market watchdogs consider the stock to be active.

How has ASBP stock performed recently?

Aspire Biopharma Holdings Inc [ASBP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.89. With this latest performance, ASBP shares dropped by -65.66% in over the last four-week period, additionally sinking by -76.96% over the last 6 months – not to mention a drop of -99.21% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASBP stock in for the last two-week period is set at 28.31, with the RSI for the last a single of trading hit 0.0179, and the three-weeks RSI is set at 0.0337 for Aspire Biopharma Holdings Inc [ASBP]. The present Moving Average for the last 50 days of trading for this stock 0.2440, while it was recorded at 0.0927 for the last single week of trading, and 0.4321 for the last 200 days.

Aspire Biopharma Holdings Inc [ASBP]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Aspire Biopharma Holdings Inc [ASBP] shares currently have an operating margin of -901693.30% and a Gross Margin at 45.54%.

Aspire Biopharma Holdings Inc (ASBP) Capital Structure & Debt Analysis

Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics

Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics

Insider trade positions for Aspire Biopharma Holdings Inc [ASBP]

There are presently around $2.91%, or 3.67%% of ASBP stock, in the hands of institutional investors.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.